Sectors
CGON
CG Oncology, Inc.
75.16
2 x 53.62
2 x 92.80
bid
ask
+
0.82
1.10%
2 @ 07:50 PM
76.05 +0.89 (1.18%)
| Ytd | 81.02% | |
| 1y | 180.24% |
72.12
day range
76.14
26.25
52 week range
80.97
| Open | 74.09 | Prev Close | 74.34 | Low | 72.12 | High | 76.14 | Mkt Cap | 6.66B |
| Vol | 840.74K | Avg Vol | 979.82K | EPS | -2.69 | P/E | N/A | Forward P/E | -24.88 |
| Beta | 0.23 | Short Ratio | 12.96 | Inst. Own | 113.61% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-09 | 50-d Avg | 72.86 | 200-d Avg | 60.22 | 1yr Est | 91.08 |
| Income Statement | |||
| Total Revenue | 1.16M | ||
| Revenues (USD) | 1.16M | ||
| Cost of Revenue | 3.93M | ||
| Gross Profit | -2.77M | ||
| Operating Expenses | 83.63M | ||
| Research and Development Expense | 54.66M | ||
| Selling, General and Administrative Expense | 28.98M | ||
| Operating Income | -86.40M | ||
| Net Income | -79.06M | ||
| Net Income Common Stock | -79.06M | ||
| Net Income Common Stock (USD) | -79.06M | ||
| Consolidated Income | -79.06M | ||
| Earnings per Basic Share | -0.90 | ||
| Earnings per Basic Share (USD) | -0.90 | ||
| Earnings per Diluted Share | -0.90 | ||
| Earning Before Interest & Taxes (EBIT) | -79.06M | ||
| Earning Before Interest & Taxes (USD) | -79.06M | ||
| Weighted Average Shares | 88.20M | ||
| Weighted Average Shares Diluted | 88.20M | ||
| Balance Sheet | |||
| Cash and Equivalents | 19.64M | ||
| Cash and Equivalents (USD) | 19.64M | ||
| Investments | 1.01B | ||
| Investments Current | 1.01B | ||
| Trade and Non-Trade Receivables | 417.00K | ||
| Current Assets | 1.05B | ||
| Property, Plant & Equipment Net | 20.44M | ||
| Total Assets | 1.09B | ||
| Debt Current | 985.00K | ||
| Total Debt | 8.82M | ||
| Current Liabilities | 47.24M | ||
| Debt Non-Current | 7.83M | ||
| Total Liabilities | 56.54M | ||
| Accumulated Retained Earnings (Deficit) | -518.23M | ||
| Shareholders Equity | 1.03B | ||
| Shareholders Equity (USD) | 1.03B | ||
| Assets Non-Current | 36.01M | ||
| Total Debt (USD) | 8.82M | ||
| Goodwill and Intangible Assets | 10.84M | ||
| Inventory | 1.00M | ||
| Liabilities Non-Current | 9.30M | ||
| Trade and Non-Trade Payables | 12.73M | ||
| Tax Liabilities | 307.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 875.00K | ||
| Net Cash Flow from Financing | 1.92M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -14.06M | ||
| Capital Expenditure | -468.00K | ||
| Issuance (Purchase) of Equity Shares | 1.94M | ||
| Net Cash Flow from Investing | 30.43M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 30.90M | ||
| Net Cash Flow from Operations | -46.41M | ||
| Share Based Compensation | 14.33M | ||